Chugai Pharmaceutical Co Ltd - Company Profile
Powered by
All the data and insights you need on Chugai Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Chugai Pharmaceutical Co Ltd Strategy Report
- Understand Chugai Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Chugai Pharmaceutical Co Ltd patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
WO2022191306A1 | Application | PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF MYASTHENIA GRAVIS | September 15, 2022 | |
EP4056993A1 | Application | VERFAHREN ZUR MESSUNG DER VISKOSITÄT EINER PROTEINLÖSUNG | C07K16/00; C07K16/18; C07K16/2866; C07K16/303; C07K16/36; C07K2317/24; C07K2317/31; C07K2317/90; C07K2317/94; G01N11/00; G01N2011/006; G01N2223/054; G01N2223/612; G01N23/201; G01N33/487; G01N33/6803; G01N33/6854 | September 14, 2022 |
EP4056580A1 | Application | VERFAHREN ZUM HERSTELLEN EINER PEPTIDVERBINDUNG, DIE EINE STERISCH GEHINDERTE AMINOSÄURE UMFASST | C07K1/04; C07K1/06; C07K1/061; C07K7/64; Y02P20/55 | September 14, 2022 |
DK3269809T3 | Application | MODIFICERET AMINOACYL-tRNA-SYNTETASE OG ANVENDELSE DERAF | C12N15/09; C12N15/70; C12N5/10; C12N9/00; C12N9/22; C12N9/93; C12P19/34; C12P21/00; C12P21/02 | September 12, 2022 |
CN109312326B | Grant | 抗-C5抗体及使用方法 | A61K2039/505; A61P7/00; C07K16/18; C07K2317/24; C07K2317/33; C07K2317/34; C07K2317/55; C07K2317/56; C07K2317/567; C07K2317/76; C07K2317/92; C07K2317/94 | September 09, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer